These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 27522496

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intraventricular haemorrhage due to re-ruptured arteriovenous malformation cleared with tissue plasminogen activator administered through a pre-existing ventriculoperitoneal shunt.
    Souslian FG, Nussbaum ES, Patel PD.
    Br J Neurosurg; 2023 Jun; 37(3):460-463. PubMed ID: 31942806
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intraventricular hemorrhage after ventriculoperitoneal shunt revision: a retrospective review.
    Calayag M, Paul AR, Adamo MA.
    J Neurosurg Pediatr; 2015 Jul; 16(1):42-5. PubMed ID: 25860981
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intraventricular Tissue Plasminogen Activator and Shunt Dependency in Aneurysmal Subarachnoid Hemorrhage Patients With Cast Ventricles.
    Catapano JS, Rumalla K, Karahalios K, Srinivasan VM, Labib MA, Cole TS, Baranoski JF, Rutledge C, Rahmani R, Jadhav AP, Ducruet AF, Albuquerque FC, Zabramski JM, Lawton MT.
    Neurosurgery; 2021 Nov 18; 89(6):973-977. PubMed ID: 34460915
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ventricular reservoir versus ventriculosubgaleal shunt for posthemorrhagic hydrocephalus in preterm infants: infection risks and ventriculoperitoneal shunt rate.
    Wang JY, Amin AG, Jallo GI, Ahn ES.
    J Neurosurg Pediatr; 2014 Nov 18; 14(5):447-54. PubMed ID: 25148212
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Shunt revision requirements after posthemorrhagic hydrocephalus of prematurity: insight into the time course of shunt dependency.
    Wang JY, Jackson EM, Jallo GI, Ahn ES.
    Childs Nerv Syst; 2015 Nov 18; 31(11):2123-30. PubMed ID: 26248674
    [Abstract] [Full Text] [Related]

  • 16. Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.
    Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron JL, Huang J, Camarata P, Lara LR, Dlugash R, McBee N, Eslami V, Hanley DF, Ziai WC, CLEAR III Trial Investigators.
    Neurology; 2017 Jul 25; 89(4):355-362. PubMed ID: 28659429
    [Abstract] [Full Text] [Related]

  • 17. Application of the Ommaya Reservoir in Managing Ventricular Hemorrhage.
    Yang XT, Feng DF, Zhao L, Sun ZL, Zhao G.
    World Neurosurg; 2016 May 25; 89():93-100. PubMed ID: 26724628
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intraventricular administration of human recombinant plasminogen activator for posthemorrhagic hydrocephalus of the newborn.
    Nowak S, Rudecka M, Polis L.
    Acta Paediatr; 1999 Mar 25; 88(3):348-9. PubMed ID: 10229053
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.